Noesis Capital Mangement Corp bought a new stake in UnitedHealth Group Inc (NYSE:UNH) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 1,678 shares of the healthcare conglomerate’s stock, valued at approximately $409,000.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Eastern Bank grew its position in UnitedHealth Group by 2.0% during the 2nd quarter. Eastern Bank now owns 69,088 shares of the healthcare conglomerate’s stock worth $16,858,000 after purchasing an additional 1,375 shares during the period. Enterprise Bank & Trust Co acquired a new stake in UnitedHealth Group during the 1st quarter worth about $3,785,000. Private Advisors LLC grew its position in UnitedHealth Group by 57.9% during the 1st quarter. Private Advisors LLC now owns 6,501 shares of the healthcare conglomerate’s stock worth $1,607,000 after purchasing an additional 2,385 shares during the period. Capital Investment Advisors LLC grew its position in UnitedHealth Group by 26.2% during the 2nd quarter. Capital Investment Advisors LLC now owns 6,379 shares of the healthcare conglomerate’s stock worth $1,556,000 after purchasing an additional 1,323 shares during the period. Finally, Calton & Associates Inc. grew its position in UnitedHealth Group by 22.7% during the 2nd quarter. Calton & Associates Inc. now owns 2,074 shares of the healthcare conglomerate’s stock worth $506,000 after purchasing an additional 384 shares during the period. 85.37% of the stock is currently owned by hedge funds and other institutional investors.
UNH has been the topic of several recent analyst reports. Cleveland Research reissued a “buy” rating on shares of UnitedHealth Group in a research note on Monday, July 15th. Morgan Stanley increased their target price on shares of UnitedHealth Group from $285.00 to $298.00 and gave the stock an “overweight” rating in a research note on Friday, July 12th. Zacks Investment Research raised shares of UnitedHealth Group from a “sell” rating to a “buy” rating and set a $269.00 target price on the stock in a research note on Monday, July 22nd. Oppenheimer set a $312.00 target price on shares of UnitedHealth Group and gave the stock a “buy” rating in a research note on Friday, July 19th. Finally, Royal Bank of Canada set a $311.00 target price on shares of UnitedHealth Group and gave the stock a “buy” rating in a research note on Friday, July 19th. One analyst has rated the stock with a sell rating, one has issued a hold rating and eighteen have issued a buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $295.06.
Shares of UNH stock traded down $4.63 during mid-day trading on Thursday, hitting $235.72. 1,608,121 shares of the stock were exchanged, compared to its average volume of 3,151,811. The firm has a fifty day moving average of $251.29 and a 200 day moving average of $247.40. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.62. UnitedHealth Group Inc has a 52-week low of $208.07 and a 52-week high of $287.94. The company has a market cap of $231.91 billion, a PE ratio of 18.30, a price-to-earnings-growth ratio of 1.30 and a beta of 0.61.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share for the quarter, beating the Zacks’ consensus estimate of $3.46 by $0.14. The firm had revenue of $60.60 billion for the quarter, compared to analyst estimates of $60.59 billion. UnitedHealth Group had a net margin of 5.51% and a return on equity of 25.20%. UnitedHealth Group’s quarterly revenue was up 8.0% compared to the same quarter last year. During the same period last year, the company posted $3.14 EPS. Equities analysts predict that UnitedHealth Group Inc will post 14.84 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Investors of record on Monday, September 16th will be paid a $1.08 dividend. This represents a $4.32 dividend on an annualized basis and a yield of 1.83%. The ex-dividend date of this dividend is Friday, September 13th. UnitedHealth Group’s dividend payout ratio is presently 33.54%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Recommended Story: What is Green Investing?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.